Moderna Drops 11%, ImmunityBio Slide Wakes Biotech Rout
Biotech shares retreat as Moderna slides 11% and ImmunityBio falls, with Sarepta also sinking amid a broad market rot...
Discover which Dividend Etf ranks lowest in fees with a quick fee-focused comparison. Find affordable options and learn how expense ratios affect your returns.
21,760 articlesBiotech shares retreat as Moderna slides 11% and ImmunityBio falls, with Sarepta also sinking amid a broad market rot...
Bitcoin is under renewed pressure as on-chain signals show a large drawdown from the short-term holder cohort. About ...
Figma posted impressive numbers in early 2026, yet the stock slumped. This article breaks down the drivers behind fig...
Webull’s March-quarter results reveal a bold pivot: the CEO says B2B revenue could rival or surpass retail in the com...
Synopsys stock faces near-term headwinds despite rising revenue, as margins and debt weigh on the long-term outlook. ...
Ferrari's latest results underscore its asset-like status, delivering strong cash flow while preparing for an electri...
When studios tweak a story to save costs, it isn’t just a movie change—it’s a money lesson. Learn how the princess di...
As renewed scrutiny of Jeffrey Epstein's network surfaces, investors and philanthropists face reputational risk that ...
A fresh BIT report shows the long-standing links between stocks, gold, and Bitcoin breaking down as investors chase s...
AI excitement can push stocks higher fast, but pullbacks test investors. This guide explains how to read a bull marke...
Europe confronts a rocket shortage leaves europe that threatens space infrastructure, defense planning, and private i...
House Democrats introduced the Death Bets Act to outlaw prediction markets tied to war outcomes and fatalities amid o...